![](https://financialmodelingprep.com/image-stock/ACET.png)
Adicet Bio, Inc. (ACET)
Adicet Bio, Inc., a biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for cancer and other diseases. The company offers gamma delta T cells engineered with chimeric antigen receptors and T cell receptor-like antibodies to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune response, and enhance persistence for durable activity in patients. Its lead product in pipeline includes ADI-001, which is in Phase I clinical study for the treatment of non-Hodgkin's lymphoma. The company also engages in the development of ADI-002, which is undergoing preclinical studies for the treatment of various solid tumors. Adicet Bio, Inc. is based in Boston, Massachusetts.
$121.95M
Mr. Chen Schor BA, CPA, CPA, M.B.A., MBA
86.00
Boston, MA
Jan 26, 2018
-0.59
$-2.52
12.52
12.75
-1,064.77%
-0.95
-0.07
0.56
9.20
12.75
-51.07%
-63.95%
Similar stocks (16)
Agios Pharmaceuticals, Inc.
AGIO
Keros Therapeutics, Inc.
KROS
Edgewise Therapeutics, Inc.
EWTX
Cullinan Oncology, Inc.
CGEM
Pliant Therapeutics, Inc.
PLRX
Stoke Therapeutics, Inc.
STOK
IGM Biosciences, Inc.
IGMS
Alector, Inc.
ALEC
Nkarta, Inc.
NKTX
Monte Rosa Therapeutics, Inc.
GLUE
Acrivon Therapeutics, Inc. Common Stock
ACRV
Tenaya Therapeutics, Inc.
TNYA
Vor Biopharma Inc.
VOR
Aerovate Therapeutics, Inc.
AVTE
Anebulo Pharmaceuticals, Inc.
ANEB
Aadi Bioscience, Inc.
AADI
ETF Exposure (11)
iShares Micro-Cap ETF
IWC
0.0253%
Vanguard Balanced Index Fund Institutional Shares
VBAIX
0%
Vanguard Balanced Index Fund Admiral Shares
VBIAX
0%
Vanguard Balanced Index Fund
VBINX
0%
Vanguard Extended Market Index Fund Institutional Shares
VIEIX
0%
Vanguard Institutional Total Stock Market Index Fund Institutional Shares
VITNX
0%
Vanguard Institutional Total Stock Market Index Fund
VITPX
0%
Vanguard Total Stock Market Index Fund
VITSX
0%
Vanguard Total Stock Market Index Fund
VTI
0%
Vanguard Total Stock Market Index Fund
VTSAX
0%
Vanguard Extended Market Index Fund
VXF
0%
Similar stocks (16)
Agios Pharmaceuticals, Inc.
AGIO
Keros Therapeutics, Inc.
KROS
Edgewise Therapeutics, Inc.
EWTX
Cullinan Oncology, Inc.
CGEM
Pliant Therapeutics, Inc.
PLRX
Stoke Therapeutics, Inc.
STOK
IGM Biosciences, Inc.
IGMS
Alector, Inc.
ALEC
Nkarta, Inc.
NKTX
Monte Rosa Therapeutics, Inc.
GLUE
Acrivon Therapeutics, Inc. Common Stock
ACRV
Tenaya Therapeutics, Inc.
TNYA
Vor Biopharma Inc.
VOR
Aerovate Therapeutics, Inc.
AVTE
Anebulo Pharmaceuticals, Inc.
ANEB
Aadi Bioscience, Inc.
AADI
ETF Exposure (11)
iShares Micro-Cap ETF
IWC
0.0253%
Vanguard Balanced Index Fund Institutional Shares
VBAIX
0%
Vanguard Balanced Index Fund Admiral Shares
VBIAX
0%
Vanguard Balanced Index Fund
VBINX
0%
Vanguard Extended Market Index Fund Institutional Shares
VIEIX
0%
Vanguard Institutional Total Stock Market Index Fund Institutional Shares
VITNX
0%
Vanguard Institutional Total Stock Market Index Fund
VITPX
0%
Vanguard Total Stock Market Index Fund
VITSX
0%
Vanguard Total Stock Market Index Fund
VTI
0%
Vanguard Total Stock Market Index Fund
VTSAX
0%
Vanguard Extended Market Index Fund
VXF
0%